BERGER FRANKLIN M Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
13
Insider Buys Sum
$5.84M
Insider Sells Quantity
8
Insider Sells Sum
$1.97M

Insider Activity of BERGER FRANKLIN M

Biography of BERGER FRANKLIN M

No biography is available at this moment.

2025-01-16PurchaseAtea Pharmaceuticals, Inc.
AVIR
director
10,000
0.0119%
$3.36$33,614-5.41%
2025-01-15PurchaseAtea Pharmaceuticals, Inc.
AVIR
director
15,000
0.0175%
$3.19$47,885-5.12%
2024-12-10SaleAtea Pharmaceuticals, Inc.
AVIR
director
359,606
0.42%
$2.85$1.02M+6.97%
2022-11-22PurchaseRain Therapeutics Inc.
RAIN
director
77,000
0.2326%
$8.27$636,790
2022-11-21PurchaseRain Therapeutics Inc.
RAIN
director
45,000
0.141%
$7.80$351,000
2022-11-14SaleAtea Pharmaceuticals, Inc.
AVIR
director
16,166
0.0289%
$5.16$83,352-31.57%
2022-11-11SaleAtea Pharmaceuticals, Inc.
AVIR
director
25,500
0.0455%
$5.15$131,333-32.4%
2022-11-08PurchaseRain Therapeutics Inc.
RAIN
director
42,881
0.1344%
$5.83$249,996
2021-09-21PurchaseRain Therapeutics Inc.
RAIN
director
3,786
0.0142%
$14.30$54,140
2021-04-23PurchaseRain Enhancement Technologies Holdco Inc
RAIN
director
125,000
0.644%
$16.95$2.12M
2021-04-23PurchaseRain Therapeutics Inc.
RAIN
director
250,000
1.2879%
$16.95$4.24M
2020-11-03PurchaseAtea Pharmaceuticals, Inc.
AVIR
director
41,666
0.3462%
$24.00$999,984+10.66%
2013-08-20PurchaseEterna Therapeutics Inc.
ERNA
director
500
0.0085%
$3.71$1,855+73.68%
2013-08-20PurchaseLineage Cell Therapeutics, Inc.
LCTX
director
1,000
0.0018%
$3.71$3,709-5.78%
Total: 14
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.